The Effects AZD8529 on Cognition and Negative Symptoms in Schizophrenics

NCT00986531 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: AZD8529
DRUG: Placebo to match AZD8529

Sponsor

AstraZeneca